Lexeo Therapeutics (LXEO) Gains from Investment Securities: 2022-2024
Historic Gains from Investment Securities for Lexeo Therapeutics (LXEO) over the last 3 years, with Dec 2024 value amounting to $410,000.
- Lexeo Therapeutics' Gains from Investment Securities fell 2.78% to $105,000 in Q4 2023 from the same period last year, while for Dec 2023 it was $425,000, marking a year-over-year change of. This contributed to the annual value of $410,000 for FY2024, which is 3.53% down from last year.
- Lexeo Therapeutics' Gains from Investment Securities amounted to $410,000 in FY2024, which was down 3.53% from $425,000 recorded in FY2023.
- In the past 5 years, Lexeo Therapeutics' Gains from Investment Securities registered a high of $425,000 during FY2023, and its lowest value of $163,000 during FY2022.
- In the last 3 years, Lexeo Therapeutics' Gains from Investment Securities had a median value of $410,000 in 2024 and averaged $332,667.
- Its Gains from Investment Securities has fluctuated over the past 5 years, first soared by 160.74% in 2023, then fell by 3.53% in 2024.
- Lexeo Therapeutics' Gains from Investment Securities (Yearly) stood at $163,000 in 2022, then skyrocketed by 160.74% to $425,000 in 2023, then declined by 3.53% to $410,000 in 2024.